More than half of patients alive two years after receiving CAR-T therapy for diffuse large B-cell lymphoma in ZUMA-1 trial
A follow-up analysis of patients enrolled in a Phase I/II multi-center trial for diffuse large B-cell lymphoma (DLBCL) reported 51 percent of patients receiving an anti-CD19 chimeric antigen receptor (CAR T) called axi-cel were still alive two years post-treatment. Axi-cel was approved by the U.S. Food and Drug Administration for treatment of DLBCL in October 2017 and by the European Commission in August 2018.
The study, co-led...
MD Anderson, Houston Dynamo team up for one goal: end cancer
Â鶹ӳ» MD Anderson Cancer Center and the Houston Dynamo today announced plans to work together toward one goal: end cancer...
Peers choose MD Anderson’s Gershenwald, Hwu as new AAAS Fellows
Two leaders in the field of melanoma treatment – a surgeon and an oncologist – from Â鶹ӳ» MD Anderson Cancer Center have...
Stand Up to Cancer funds innovative approach to pancreatic cancer
Research on a new way of deploying the immune system against pancreatic cancer, an exceptionally lethal cancer that has so far resisted new immunotherapies, will receive $1 million in initial funding from Stand Up to Cancer.
The project led by researchers from Â鶹ӳ» MD Anderson Cancer Center and Baylor College of Medicine will collect T cells – the immune system’s targeted warriors – from tumors, expand their...
Investigational drug shows promising results in Phase II study of aggressive, often fatal blood disorder with no approved therapies
A Phase I/II study, led by investigators at Â鶹ӳ» MD Anderson Cancer Center, reports an investigational drug called tagraxofusp...
Immunotherapy combination and chemotherapy show encouraging results in Phase II acute myeloid leukemia study
A triple therapy combining two immune checkpoint inhibitors (ICPIs) with the standard-of-care chemotherapy, a hypomethylating agent called...
First UT System clinical collaboration launches between MD Anderson, UTMB Health
Â鶹ӳ» MD Anderson Cancer Center today formally opened a four-story facility in League City that houses new and expanded...